All Stories

  1. Association of neurologic deficits with surgical outcomes and health‐related quality of life after treatment for metastatic epidural spinal cord compression
  2. Image guidance in spine tumor surgery
  3. Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice
  4. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study
  5. Minimal Access Surgery for Spinal Metastases: Prospective Evaluation of a Treatment Algorithm Using Patient Reported Outcomes
  6. Current Role of Uninstrumented Lumbar Fusion
  7. State of the Art Treatment of Spinal Metastatic Disease
  8. Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery
  9. Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis
  10. Predictors of quality of life improvement after surgery for metastatic tumors of the spine: prospective cohort study
  11. Validation of Spinal Instability Neoplastic Score Components through Patient-Reported Outcomes
  12. 178 Hybrid Surgery-Radiosurgery Therapy for Metastatic Epidural Spinal Cord Compression (MESCC): A Prospective Evaluation Using Patient-Reported Outcomes
  13. Continuous mapping of the corticospinal tracts in intramedullary spinal cord tumor surgery using an electrified ultrasonic aspirator
  14. Hybrid surgery–radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes
  15. Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease
  16. Clinical outcomes following resection of giant spinal schwannomas: a case series of 32 patients
  17. Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors
  18. Letter to the Editor: Evoked potentials and Chiari malformation Type 1
  19. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery
  20. Pediatric Intradural Spinal Cord Tumors
  21. A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells
  22. The value of multimodality intraoperative neurophysiological monitoring in treating pediatric Chiari malformation type I
  23. Novel antiphospholipid antibodies in autoimmune bullous diseases
  24. Erratum to: Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis
  25. Intraoperative Seizures During Awake Craniotomy
  26. Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor
  27. Helicobacter pylori serology in autoimmune diseases – fact or fiction?
  28. Outcome of Elderly Patients Undergoing Awake-Craniotomy for Tumor Resection
  29. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden
  30. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases
  31. Medical students' self-report of mental health conditions
  32. Autoimmune bullous diseases
  33. Infectious Serologies and Autoantibodies in Hepatitis C and Autoimmune Disease-Associated Mixed Cryoglobulinemia
  34. Geographical Differences in Autoantibodies and Anti-infectious Agents Antibodies Among Healthy Adults
  35. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis
  36. Three-dimensional surface imaging for clinical trials: Improved precision and reproducibility in circumference measurements of thighs and abdomens
  37. Common infectious agents prevalence in antiphospholipid syndrome
  38. Infectious antibodies in systemic lupus erythematosus patients
  39. Anti-infectious Antibodies and Autoimmune-associated Autoantibodies in Patients with Type I Diabetes Mellitus and their Close Family Members
  40. Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease
  41. Antitreponemal Antibodies Leading to Autoantibody Production and Protection from Atherosclerosis in Kitavans from Papua New Guinea
  42. Autoantibody Screen in Inflammatory Myopathies High Prevalence of Antibodies to Gliadin
  43. Exposure to Epstein-Barr Virus Infection Is Associated with Mild Systemic Lupus Erythematosus Disease
  44. Gluten Sensitivity in Multiple Sclerosis
  45. Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and Other Vasculitides
  46. Infectious Serologies and Autoantibodies in Inflammatory Bowel Disease
  47. The Role of Infections in the Immunopathogensis of Systemic Sclerosis-Evidence from Serological Studies
  48. Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis
  49. Prevalence of hepatitis C serum antibody in autoimmune diseases
  50. Infections and autoimmune thyroid diseases: Parallel detection of antibodies against pathogens with proteomic technology
  51. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders
  52. Neuropsychiatric lupus and infectious triggers
  53. Viral infection can induce the production of autoantibodies
  54. Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome
  55. Epstein Barr Virus and Cytomegalovirus in Autoimmune Diseases: Are They Truly Notorious? A Preliminary Report
  56. Molecular mimicry and auto-immunity
  57. Molecular mimicry and auto-immunity
  58. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS
  59. Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies